Videos

Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.

Cardiology employment models undergoing a dramatic shift

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

Tom Price, MD, an orthopedic surgeon, and former secretary of Health and Human Services (HHS) during the first Trump administration has been an advocate for changing immigration policy to help solve the growing shortage of doctors and nurses in the U.S. He explains what is needed for bipartisan legislation to make it easier to recruit foreign doctors.

Former HHS Secretary Tom Price: Immigration reform could alleviate healthcare staffing crisis

Tom Price, MD, an orthopedic surgeon, and former secretary of Health and Human Services (HHS) is an advocate for changing immigration policy to help solve the growing shortage of doctors and nurses in the U.S.

Arlene Sussman, MD, radiologist-medical director, mammography, at vRad, explains a telebreast imaging system that allows patients direct video consults with their remote radiologist just after their exams to increase personalized care and to answer questions immediately to avoid waiting for answers. She spoke on this technology in sessions at RSNA 2024.

Creating real-time telebreast imaging that includes remote patient consults

Arlene Sussman, MD, medical director with vRad, explains a telebreast imaging system that allows patients direct video consults with a remote radiologist just after their exams to increase personalized care and answer questions immediately.

 

Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

Srihari S. Naidu, MD, FACC, FAHA, MSCAI, assumed the role of president of the Society for Cardiovascular Angiography and Interventions (SCAI) May 3 during the society's annual meeting. He outlined his ambitious plans to take SCAI in some new directions. #SCAI #SCAI2025

New SCAI president lists advocacy, cardiogenic shock among his top priorities

Srihari Naidu, MD, spoke to Cardiovascular Business about his plan to take SCAI in some bold new directions.

Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

Philippe Genereux, MD, director of the structural heart program at Morristown Medical Center, principal investigator of the late-breaking EARLY TAVR trial, presented new data at ACC 2025 showing intervening earlier on patients with asymptomatic severe aortic stenosis leads to better outcomes.

Latest EARLY TAVR data suggest it is time to update industry guidelines

Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate.